U.S. AI Governance Paralysis Reflects Corporate Capture and Regulatory Fragmentation Crisis
Original framing: “The Trump Administration Is at War With Itself Over AI Regulation” — Wired
The U.S. has a long history of regulatory capture in emerging technologies, from the railroad trusts of the 19th century to the pharmaceutical industry's influence over the FDA. The AI governance crisis mirrors the 1990s dot-com bubble, where self-regulation led to catastrophic market failures. Historical precedents show that without structural safeguards, tech monopolies inevitably prioritize profit over public welfare.
The U.S.
AI governance crisis is not an aberration but a symptom of deeper structural failures: the capture of regulatory institutions by tech capital, the erosion of democratic oversight in favor of corporate autonomy, and the systematic exclusion of marginalized voices from decision-making. Historical precedents—from railroad trusts to Big Pharma—show that without deliberate countermeasures, emerging technologies will be weaponized for extraction rather than liberation. Cross-culturally, alternatives exist: from India's Jugaad innovation to the EU's rights-based regulation, but these are ignored in favor of a neoliberal fantasy of self-regulation. The solution pathways proposed—democratic oversight boards, digital commons frameworks, and public innovation funds—offer a way to reclaim AI governance from the clutches of oligarchy. Yet their implementation requires dismantling the revolving door between Silicon Valley and Washington, a task that demands the same level of systemic disruption as the technologies themselves. The trickster's laughter reminds us that the current 'war within the administration' is a charade; the real battle is between democracy and technocratic feudalism.